The prosthetic arteriovenous grafts (AVG) being used increasingly to create hemodialysis access are
prone to infections that pose potentially life-threatening infectious and bleeding complications, as well as loss of
dialysis access. In this study, we identified the bacteriologic agents of infected AVGs by site swab, blood culture,
and prosthesis cultures, and to evaluate the role of microbiological findings in the management of the infection